We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Beximco Pharma | LSE:BXP | London | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 36.50 | 35.00 | 38.00 | 36.50 | 36.50 | 36.50 | 105,000 | 08:00:00 |
Date | Subject | Author | Discuss |
---|---|---|---|
18/1/2017 09:45 | Hopefully dhaka gets to 95... wiggle...then to 120-150 range... pulling us up to £1 | greg the grinch | |
18/1/2017 09:21 | Closed at highest level since July in Dhaka. I would expect the interims to show some decent growth as they started to sell one of their FDA-approved drugs in the US from August 2016.... | deltrotter | |
17/1/2017 09:41 | Buy point in the chart IMO. | deltrotter | |
16/1/2017 20:17 | Quite an interesting graph Shows we have had an acc/dist phase and a rise over 95 could see a nice blue sky move. | greg the grinch | |
16/1/2017 19:58 | Interims due before end of Jan.... | deltrotter | |
16/1/2017 11:30 | Yup.... seems we will wiggle around for a bit | greg the grinch | |
16/1/2017 11:28 | I like the way, on every bit of profit taking, a load of chunky buys come in... | zcaprd7 | |
16/1/2017 10:35 | Thanks Gred - appreciated. | deltrotter | |
16/1/2017 10:17 | del, on dhaka beximco is parent company On dhaka bxpharma is the one you need to look at | greg the grinch | |
16/1/2017 07:26 | Lol. Like I said Up 9% at close yesterday when I posted. Down 1% at the moment today. Dhaka market is open on Sunday. | deltrotter | |
16/1/2017 07:13 | deltrotter, I see it as down 1%. | rogash | |
15/1/2017 12:00 | Closed up 9% on heavy volume in Dhaka today.... | deltrotter | |
11/1/2017 20:32 | Trump wants more transparency from big pharma and will not let them get away with some of the rip off multiples they have been charging. All to the good. BXP are producing cheap variants of those major's drugs so will be highly competetive. The US healtcare system has similar problems to ours and should welcome these cheaper drugs. | someuwin | |
11/1/2017 20:15 | Do we think Trumps attack on big pharma actually works well for BXP? Surely he won't mind cheap generics coming from abroad? | zcaprd7 | |
11/1/2017 20:01 | Tx someuwin | deltrotter | |
11/1/2017 09:16 | Agreed someuwin. As their mcap increases they consider a listing in the US I guess? | deltrotter | |
11/1/2017 09:11 | Over the last 13 months BXP has been granted approval from the US Food and Drug Administration to sell three different drugs into the US (blood pressure, cariovascular and Diabetes). (Two approvals in the last 3 months will be launching soon) This is just the start and as they have said "marks the beginning of a new era for the Company". | someuwin | |
11/1/2017 08:57 | Looks that - I can't help feeling this one has a long way to run from here over the coming months and years... | deltrotter | |
11/1/2017 08:37 | Next leg up? | someuwin | |
10/1/2017 20:24 | Yes..... looks like a seller came in at 65p and there is a buyer at 60p. A nice Dhaka rise will get that seller absorbed... GLA | greg the grinch | |
10/1/2017 18:01 | I meant, what caused the flurry of sells? | zcaprd7 | |
10/1/2017 16:27 | Buyers itching to get in on any pull back I'd guess.... | deltrotter |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions